Eric Stecker is a Cardiology physician affiliated with Oregon Health & Science University. OpenAlex indexes 168 publications with 5,369 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Uhn-62
Portland, OR 97239
Telephone
503-494-8750Registry record last updated 12 Aug 2008.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.2%Antiarrhythmic29.8%Amiodarone Hcl47%Flecainide Acetate29%Dofetilide24%Part D<11 patientsBeta blocker28.4%Metoprolol Succinate69%Sotalol31%Part D≥19 patientsBlood & clotting
37.9%Factor Xa inhibitor37.9%Eliquis79%Xarelto21%Part D<11 patientsMetabolism & gastrointestinal
3.9%Proton pump inhibitor3.9%Omeprazole100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiovascular disease risk: it is complicated, but race and ethnicity are key, a Bayesian network analysis
Frontiers in Public Health
2024 - Efficacy and safety of dofetilide and sotalol in patients with hypertrophic cardiomyopathy
Communications Medicine
2023 - Ablation Versus Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation: A Meta-Analysis of Randomized Trials
Circulation Arrhythmia and Electrophysiology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Brian Druker, MD
Oregon Health & Science University
Kevin Winthrop, MD
Oregon Health & Science University
Richard Maziarz, MD
Oregon Health & Science University
Wayne Clark, MD
Oregon Health & Science University
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”